Source:http://linkedlifedata.com/resource/pubmed/id/12767068
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2003-5-26
|
pubmed:abstractText |
Interleukin-23 (IL-23), a novel cytokine composed of a newly identified p19 molecule and the p40 subunit of IL-12, can stimulate the proliferation in vitro of memory T cells. We examined whether Colon 26 murine colon carcinoma cells that were retrovirally transduced with the p19-linked p40 gene (Colon 26/IL-23) could produce antitumor effects in inoculated mice. The growth of Colon 26/IL-23 tumors developed in immunocompetent mice was significantly retarded and the tumors disappeared thereafter. Spleen cells from the mice that received Colon 26/IL-23 cells produced significant amounts of interferon-gamma, when they were cultured with irradiated Colon 26 but not irrelevant cells. Depletion of CD8(+) T cells suppressed the production of interferon-gamma. The mice that had rejected Colon 26/IL-23 tumors were resistant to subsequent challenge of parent but not irrelevant tumor cells. Colon 26/IL-23 tumors were not rejected in nude mice but the growth was retarded compared to parent tumors. Treatment of nude mice with anti-asialo GM(1) antibody did not influence the growth of Colon 26/IL-23 tumors. These data suggest that expression of IL-23 in tumors produces T cell-dependent antitumor effects and induces systemic immunity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Il23a protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-23,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-23 Subunit p19,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2003 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
105
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
820-4
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:12767068-Animals,
pubmed-meshheading:12767068-CD8-Positive T-Lymphocytes,
pubmed-meshheading:12767068-Carcinoma,
pubmed-meshheading:12767068-Cell Division,
pubmed-meshheading:12767068-Colonic Neoplasms,
pubmed-meshheading:12767068-Gene Expression,
pubmed-meshheading:12767068-Gene Therapy,
pubmed-meshheading:12767068-Interferon-gamma,
pubmed-meshheading:12767068-Interleukin-23,
pubmed-meshheading:12767068-Interleukin-23 Subunit p19,
pubmed-meshheading:12767068-Interleukins,
pubmed-meshheading:12767068-Mice,
pubmed-meshheading:12767068-Mice, Inbred BALB C,
pubmed-meshheading:12767068-Mice, Nude,
pubmed-meshheading:12767068-Neoplasm Transplantation,
pubmed-meshheading:12767068-Transduction, Genetic,
pubmed-meshheading:12767068-Tumor Cells, Cultured
|
pubmed:year |
2003
|
pubmed:articleTitle |
Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells.
|
pubmed:affiliation |
Division of Pathology, Chiba Cancer Center Research Institute, Chiba, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|